Skip to main content

Advertisement

Table 1 Clinical and laboratory data of thalassemic patients with normal glucose tolerance, impaired glucose tolerance and diabetes.

From: Gradient-echo magnetic resonance imaging study of pancreatic iron overload in young Egyptian beta-thalassemia major patients and effect of splenectomy

Parameters Normal Glucose Tolerance(20) Impaired Glucose Tolerance (10) Diabetics (10)
Male/Female 14/6 5/5 6/4
  Mean ± SD Mean ± SD Mean ± SD
Age (yrs) 13.15 ± 3.56 14.80 ± 3.12 14.90 ± 2.69
Age of diagnosis (ms) 8.5 ± 6.53 7.80 ± 3.22 6.70 ± 2.50
Duration of disease(yrs) 12.42 ± 3.52 13.21 ± 3.3 14.34 ± 2.66
Duration of chelation (yrs) 5.80 ± 3.07 5.55 ± 4.31 5.90 ± 2.96
Hb (g/dL) 7.46 ± 1.24 7.53 ± 1.23 7.39 ± 0.86
AST (IU/L) 64.80 ± 44.06 86.89 ± 40.07 74.80 ± 41.52
ALT (IU/L) 66.40 ± 53.74 107.50 ± 84.53 67.70 ± 27.77
Serum ferritin (ng/ml) 1999.90 ± 932.95 3223.60 ± 2188.23 3438 ± 1327.60
FBG (mg/dL) 82.40 ± 7.16 107.8 ± 16.4 145.30 ± 29.50
PP (mg/dL) 120.80 ± 9.55 175.2 ± 17.9 236.80 ± 29.81
Frequency of blood transfusion (wk interval) 3.05 ± 0.6 3.2 ± 0.63 3.4 ± 0.84
  1. SD, standard deviation; Hb, Hemoglobin; AST, aspartate aminotransferase; ALT, alanine aminotransferase; FBG, fasting blood glucose; PP, postprandial blood glucose